Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...
Dec 10 (Reuters) - GTC Biotherapeutics Inc. said the U.S. Food and Drug Administration granted an orphan drug status to the company's ATryn drug for the treatment of patients with hereditary ...
Dose and frequency should be adjusted based on antithrombin activity, using the Innovance Antithrombin companion diagnostic test. The Food and Drug Administration (FDA) has approved Qfitlia (fitusiran ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results